OCTAGON RESEARCH SOLUTIONS PARTNERS WITH DSP CLINICAL RESEARCH TO EXTEND CLINICAL TRIAL SERVICES
Partnership expands depth and breadth of clinical services
Wayne, Pa. – January 30, 2006 – Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, today announced a new partnership with DSP Clinical Research (DSP). The partnership is aimed at leveraging the unique expertise of both organizations to offer a greater depth of knowledge and experience across an expanded collection of service offerings.
DSP Clinical Research brings a wealth of knowledge and experience in clinical trial management including investigator site management, study management and site monitoring. Octagon has significant domain expertise in clinical data strategy and management as well as the regulatory aspects of clinical drug development. The expertise presented by each partner offers a seamless approach to clients who are committed to strategic outsourcing. By connecting trial management activities to data and eventually submission management activities, greater efficiencies can be realized.
"The partnership developed as a natural extension of our project work experiences," noted Jim Walker, president and CEO of Octagon. "We have worked with DSP on several projects and found that their expertise complements our internal skill sets and enables us to jointly bring greater value to our clients. The partnership formalizes what is already a great relationship between two innovative organizations."
Darlene Panzitta, president and founder of DSP added, "DSP has extensive experience across multiple therapeutic areas in Phase I-IV clinical studies. Our partnership with Octagon allows us to broaden our services while continuing to focus on our core strengths. We are pleased to be working with an organization that approaches client engagements with the same energy, enthusiasm and level of expertise that we bring to our projects."
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and integrated solutions. Octagon is headquartered in Wayne, PA, with offices in Boston, MA, Costa Mesa, CA, and European headquarters in Amersham, UK. For more information please visit www.octagonresearch.com .
About DSP Clinical Research
DSP Clinical Research is a trial management organization whose main objective is to successfully manage clinical trials by focusing on 3 key elements: investigator site management, study management and site monitoring. DSP Clinical Research can set up and manage Phase I-IV clinical trials from study set up through NDA submission, as well as offer customized services. The company is headquartered in Fairfield, NJ, with offices in Miami, FL. For more information please visit www.dspclinical.com .
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
